Ustekinumab is Effective for Inducing Clinical, Endoscopic, and Radiographic Response and Remission in Refractory Moderate-to-Severe Crohn's Disease: A Multicentre Cohort Study

Subjects

Subjects :

0301 basic medicine
Moderate to severe
Crohn's disease
medicine.medical_specialty
Hepatology
business.industry
Radiography
Gastroenterology
medicine.disease
Surgery
03 medical and health sciences
030104 developmental biology
0302 clinical medicine
Refractory
Internal medicine
Ustekinumab
Medicine
030211 gastroenterology & hepatology
business
Cohort study
medicine.drug

Details

ISSN :

00165085

Volume :

152

Database :

OpenAIRE

Journal :

Gastroenterology

Accession number :

edsair.doi...........a43f3eaab02a74d6ac12a207d2743c96

Full Text :

https://doi.org/10.1016/s0016-5085(17)31602-5